Prognosis Innovation Healthcare Continues Path to 100% Successful Meaningful Use Attestions Upon Return of Founders

Share Article

ChartAccess® 5.0 EHR Platform Receives ONC-ACB Certification by Drummond Group

News Image
“Prognosis’ clients are set to continue a 100% success rate in regard to Meaningful Use 2014 attestations to CMS,” said Steve Everest, Prognosis President. “This is a record that we have maintained since federal attestations began in 2012."

Prognosis Innovation Healthcare (Prognosis, announced that its product, ChartAccess® version 5.0, has been tested and certified as 2014 compliant under the Drummond Group’s Electronic Health Records Office of the National Coordinator Authorized Certification Body (ONC-ACB) program.

Led by the company’s original Founders, this success qualifies Prognosis customers to take advantage of key operational benefits and receive federal stimulus monies upon demonstrating meaningful use of the technology, important to meeting the federal push for adoption of EHRs by all U.S. healthcare providers.

In addition to being evaluated against foundation standards such as HIPAA security, certified inpatient products are examined for their product functionality in regard to operational items including clinician order entry, documentation strength, and medication administration capabilities. Meeting the more stringent 2014 standards included additions to the ChartAccess software such as a barcode medicine administration, patient portal, increased state reporting requirements, and clinical quality measures (CQMs). All of these requirements are seamlessly managed by Prognosis clients through ChartAccess’ state of the art Meaningful Use Scorecard®, which provides real-time tracking tools to successfully manage progress towards CMS required Meaningful Use measurements.

“This certification enables Prognosis’ clients to continue a 100% success rate in regard to Meaningful Use 2014 attestations to CMS,” said Steve Everest, Prognosis President. “We are very proud that this is a record that Prognosis and its predecessor have maintained since federal attestations began in 2012.”

The Return of Founders

In January 2014, Prognosis announced a name change and new ownership with the return of original company founders, including John Joe, MD, MPH and Isaac Shi. Dr. Joe and Mr. Shi were the original clinical and software architects responsible for making ChartAccess one of the first six hospital EHR systems to receive full federal certification in early 2008, ahead of most competitors. Dr. Joe returns to serve as Vice-Chairman of Prognosis’ Board of Directors, reuniting his clinical and healthcare market expertise with Mr. Shi’s software expertise to empower Prognosis’ customers in enhancing patient care, reducing healthcare costs, and improving health.

“Our return to Prognosis marks a new era of excellence in customer focus, clinical functionality, and technology innovation,” said Dr. Joe. “We know first-hand the challenges faced by our customers, their providers, and their communities. We are raising the bar for customer communication, engagement, and partnership to address our customers’ needs in clinical integration and transformation, community health improvement, delivery system and payment reform, and sustainable business models in a rapidly changing and challenging healthcare environment. The customer hospital CEOs I have visited say they already experience the positives in the new Prognosis.”

[Prognosis Certified April 14, 2014,ChartAccess 5.0®, Complete EHR Certification, Cert ID No. 04142014-2366-5.] This Complete EHR is 2014 Edition compliant and has been certified by an ONC-ACB in accordance with the applicable certification criteria adopted by the Secretary of the U.S. Department of Health and Human Services. This certification does not represent an endorsement by the U.S. Department of Health and Human Services or guarantee the receipt of incentive payments. [Prognosis Innovative Healthcare Certified April 14, 2014,ChartAccess 5.0®, Complete EHR Certification, Cert ID No. 04142014-2366-5.]

About Prognosis Innovation Healthcare    
Prognosis Innovation Healthcare in Houston, Texas, is dedicated to serving community and rural hospitals across the U.S. through its comprehensive enterprise EHR solution comprised of inpatient, emergency department, ambulatory and financial applications. Prognosis’ web-native technology with advanced configurability accelerates adaptability, ease of use, speed and agility to foster user adoption, sustainability and growth. Prognosis partners with hospitals to enhance patient care by providing innovative technology in the hands of healthcare providers and hospital leaders to improve the care they provide to their communities. Visit for more information.

About Drummond Group Inc.    
Drummond Group Inc. is a global software test and certification lab that serves a wide range of vertical industries. In healthcare, Drummond Group tests and certifies Controlled Substance Ordering Systems (CSOS), Electronic Prescription of Controlled Substances (EPCS) software and processes, and Electronic Health Records (EHRs) – designating the trusted test lab as the only third-party certifier of all three initiatives designed to move the industry toward a digital future. Founded in 1999, and accredited for the Office of the National Coordinator HIT Certification Program as an Authorized Certification Body (ACB) and an Accredited Test Lab (ATL), Drummond Group continues to build upon its deep experience and expertise necessary to deliver reliable and cost-effective services. For more information, please visit or email DGI(at)drummondgroup(dot)com.


Share article on social media or email:

View article via:

Pdf Print